PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes (Q27320965)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 2013)
edit
Language Label Description Also known as
English
PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes
scientific article (publication date: 2013)

    Statements

    PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes (English)
    0 references
    0 references
    0 references
    0 references
    Katarzyna Wachowicz
    0 references
    Sandra Kaminski
    0 references
    Friedrich Fresser
    0 references
    Christina Lutz-Nicoladoni
    0 references
    Michael Leitges
    0 references
    Ramin Massoumi
    0 references
    Gottfried Baier
    0 references
    2013
    0 references
    0 references
    8
    0 references
    1
    0 references
    e53709
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit